Auszug
Neurochirurgische Patienten tragen ein hohes Risiko für tiefe Beinvenenthrombosen (TBVT) und Lungenembolien (LE): Die Inzidenz klinisch manifester TBVT ohne medikamentöse Prophylaxe beträgt 4,3%, subklinischer TBVT 19–50% [8]. LE treten bei 1,5–5% mit einer Mortalität von 9–50% auf [8]. Das höchste Risiko besteht bei Patienten mit hirneigenen Tumoren, v. a. in den ersten 2 Monaten. Die Inzidenz von TBVT beträgt hier bis zu 45% [8]. In einer kürzlich erschienen retrospektiven Analyse von 9.489 Gliompatienten, fanden sich bei 7,5% eine symptomatische LE [22]. Bei Patienten mit ischämischem Schlaganfall stellt die LE mit einer Inzidenz von bis zu 25% eine der häufigsten Todesursachen dar [12].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agnelli G, Piovella F, Buoncristiani P et al. (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80–85
Bijsterveld NR, Moons AH, Boekholdt SM (2002) Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation 106:2550–2554
Bombeli T (2002) Management von Thrombosen und Blutungen. Ein klinisches Vademecum. Bern, Göttingen, Toronto, Seattle, Verlag Hans Huber.
Brisman R, Mendell J (1973) Thromboembolism and brain tumors. J Neurosurg 38:337–338
Decousus H, Leizorovicz A, Parent F et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du risque d'embolie pulmonaire par interruption cave study group. N Engl J Med 338:409–415
Dickinson LD, Miller LD, Patel CP et al. (1998) Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43:1074–1081
Gnanalingham KK, Holland JP (2003) Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients. J Clin Neurosci 10(4):467–9
Hamilton MG, Hull RD, Pineo GF (1994) Venous thromboembolism in neurosurgery and neurology patients. Review. Neurosurgery 34:280–295
Ingerslev J, Vanek T, Culic S (2007) Use of recombinant factor VIIa for emergency reversal of anticoagulation. J Postgrad Med 53(1):17–22
Iorio A, Agnelli G (2000) Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery. A meta-analysis. Arch Intern Med 160:2327–2332
Keller IS, Meier C, Pfiffner R et al. (2007) Clinical Comparison of Two Optional Vena Cava Filters J Vasc Interv Radiol 18:505–511
Kelly J, Rudd A, Lewis R, Hunt BJ (2001) Venous thromboembolism after acute stroke. Stroke 32(1):262–7
Kujath P (2001) Perioperative Thromboseprophylaxe. Bremen, London, Boston, UNI-MED
Lacut K, Bressollette L, Le Gal G (2005) Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65:865–869
Lazio BE, Simard JM (1999) Anticoagulation in neurosurgical patients. Review. Neurosurgery 45:838–848
Ng HJ, Koh LP (2003) Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin. Ann Hematol 82: 257–8
Norwood SH, McAuley CE, Berne JD et al. (2002) Prospective evaluation of the safety of Enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg 137:696–701
Platz A, Ertel W, Helmy N et al. (2001) Erfahrungen mit dem Einsatz eines potentiell temporären Vena cava-Filters bei mehrfachverletzten Patienten. Chirurg 72:717–722
Palmer AJ, Schramm W, Kirchhof B, et al. (1997) Low molecular weight heparin and unfractionated heparin for prevention of thromboembolism in general surgery: a meta-analysis of randomised clinical trials. Haemostasis 27:65–74
Powers SK, Edwards MS (1985) Prevention and treatment of thrmoboembolic complications in a neurosurgical patient. In: Wilkins RH, Rengachary SS (Hrsg) Neurosurgery. New York, McGraw-Hill, S 406–410
Raabe A, Gerlach R, Zimmermann M et al. (2001) The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien) 143:1–7
Semrad TJ, O'Donnell R, Wun T et al. (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106(4):601–8
Streiff MB (2000) Venal caval filters: A comprehensive review. Blood 15:3669–3677
Van Gijn J, Rinkel GJ (2001) Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124(2):249–78
Wen DY, Hall WA (1998) Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol 50:521–525
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Keller, E., Yaldizli, Ö., Bombeli, T. (2008). Thromboembolieprophylaxe. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68317-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-68317-9_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23051-9
Online ISBN: 978-3-540-68317-9
eBook Packages: Medicine (German Language)